Paul Salva
Pediatric Pulmonology · Springfield, MANPI 1114914363
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 72.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $11,031 and has fallen 95.2% since, to $529 in 2025.
Across 469 payments — averaging $45.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$15K
- GSK$1K
- Sanofi$918
- Regeneron Healthcare Solutions, Inc.$784
- Amgen$767
- Novartis$763
- plus $1K from 9 others
What the payments were for
- Speaking & faculty fees$11,40054%
- Travel & lodging$930%
- Food & beverage$9,59045%
- Education$900%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 154 | $15,286 |
| GSK | 52 | $1,176 |
| Sanofi | 47 | $918 |
| Regeneron Healthcare Solutions, Inc. | 40 | $784 |
| Amgen | 40 | $767 |
| Novartis | 70 | $763 |
| Genentech USA, Inc. | 30 | $697 |
| Boehringer Ingelheim | 13 | $281 |
| Teva Pharmaceuticals USA, Inc. | 7 | $119 |
| Sanofi-aventis U.S. LLC | 3 | $119 |
| Covis Pharma GmbH | 6 | $99 |
| CSL Behring | 2 | $58 |
| Sobi, Inc | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Pharming Healthcare, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,174 in reported general payments places this provider in the 85th percentile of 40 pediatric pulmonology providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 11 | $42,053 |
| Azithromycin | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other pediatric pulmonology in Springfield
- Nico VehseSpringfield$106
- Gregory SawickiBoston$96K
- Claudia OrdonezBoston$73K
- Thomas KinaneBoston$67K
- Ahmet UluerBoston$61K
- Lael YonkerBoston$21K
- Robyn CohenBoston$16K
- Scott SchroederBoston$9K
- Henry DorkinBoston$6K
- Gary VisnerBoston$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.